Donald Fresne , President And CEO Of Egenix, Inc. Is Pleased To Announce The Appointment Of Adrian Schwarzer, MD, Ph.D. To Its Scientific Advisory Committee at the Institute of Experimental Hematology and resident in the Department of Hematology, Oncology and Stem Cell Transplantation.
http://www.biospace.com/news_story.aspx?StoryID=319352&full=1
http://www.biospace.com/news_story.aspx?StoryID=319352&full=1
No comments:
Post a Comment